HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mefloquine failure in a case of falciparum malaria induced with a multidrug-resistant isolate in a non-immune subject.

Abstract
In a volunteer with infection induced by injection of the mefloquine-sensitive, multidrug-resistant Vietnam Smith isolate of P. falciparum, parasitemia recurred following treatment with the candidate antimalarial drug enpiroline. Parasitemia also recurred after subsequent treatment with mefloquine and again after retreatment with the same drug. All recurrences were at the RI level. Parasite drug sensitivities determined by a semi-automated isotope microdilution method after the second and third recurrences revealed a progressive decrease in sensitivity to all arylaminoalcohols tested (halofantrine, enpiroline, and mefloquine). Decreased sensitivity persisted after 30 days of isolate culture. The parallel changes in parasite sensitivity to the synthetic arylaminoalcohols argue for development of drugs which are chemically dissimilar.
AuthorsT M Cosgriff, C L Pamplin, C J Canfield, G P Willet
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 34 Issue 4 Pg. 692-3 (Jul 1985) ISSN: 0002-9637 [Print] United States
PMID3896001 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antimalarials
  • Phenanthrenes
  • Pyridines
  • Quinolines
  • Chloroquine
  • enpiroline
  • Quinine
  • halofantrine
  • Mefloquine
Topics
  • Adult
  • Antimalarials (pharmacology, therapeutic use)
  • Chloroquine (pharmacology)
  • Drug Resistance, Microbial
  • Humans
  • Malaria (drug therapy, parasitology)
  • Male
  • Mefloquine
  • Phenanthrenes (pharmacology)
  • Plasmodium falciparum (drug effects)
  • Pyridines (pharmacology)
  • Quinine (pharmacology)
  • Quinolines (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: